Partner Mike Fuller was quoted in, “COVID-19 Partnerships Without Formal Contracts Pose Risks, From Potential Liability To IP Issues,” an article published by Pink Sheet.

Partner Mike Fuller was quoted in, “COVID-19 Partnerships Without Formal Contracts Pose Risks, From Potential Liability To IP Issues,” an article published by Pink Sheet.

Excerpt: “Biopharma companies are jumping into partnerships to develop COVID-19 treatments before signing a formal agreement so they can begin research immediately.”

Read full article here >> (Subscription Required)